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Highlights 
 Hip osteoarthritis kinematics are measured with wearable sensors. 
 Results for novel method agrees well with literature. 
 RehaGait® use for hip osteoarthritis is feasible 
 
Abstract 
Background: The popularity of inertial sensors in gait analysis is steadily rising. To date, an 
application of a wearable inertial sensor system for assessing gait in hip osteoarthritis (OA) 
has not been reported. 
Research question: Can the known kinematic differences between patients with hip OA and 
asymptomatic control subjects be measured using the inertial sensor system RehaGait®? 
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Methods: The patients group consisted of 22 patients with unilateral hip OA scheduled for 
total hip replacement. Forty-five age matched healthy control subjects served as control 
group. All subjects walked for a distance of 20 meters at their self-selected speed. 
Spatiotemporal parameters and sagittal kinematics at the hip, knee, and ankle including range 
of motion (ROM) were measured using the RehaGait® system.  
Results: Patients with hip OA walked at a slower walking speed (-0.18m/s, P<0.001) and with 
shorter stride length (-0.16m, P<0.001), smaller hip ROM during stance (-11.6°, P<0.001) and 
swing (-11.3°, P<0.001) and smaller knee ROM during terminal stance and swing (-9.0° 
and -11.5°, P<0.001). Patients had a smaller hip ROM during stance and swing and smaller 
knee ROM during terminal stance and swing in the affected compared to the unaffected side 
(P<0.001). 
Significance: The differences in spatiotemporal and kinematic gait parameters between 
patients with hip OA and age matched control subjects assessed using the inertial sensor 
system agree with those documented for camera-based systems. Hence, the RehaGait® 
system can measure gait kinematics characteristic for hip OA, and its use in daily clinical 
practice is feasible. 
 
Key words: inertial sensors; hip osteoarthritis; gait analysis; wearable sensors; kinematics 
 
1. Introduction 
 
Hip osteoarthritis (OA) is a very common disease that will affect 25% of the 
population in the course of a lifetime [1]. Its prevalence is expected to increase over the next 
decades because of the aging population [2]. The potential of gait analysis in understanding 
the OA disease process and its treatment has long been recognized [3]. For instance, gait 
analysis can help understand the underlying gait adaptation processes, assist in designing 
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conservative and surgical management strategies as well as evaluate the treatment outcome. 
Various studies have reported spatiotemporal and kinematic changes in patients with OA [3-
10]. Most of these studies performed the measurements in a dedicated gait laboratory using 
reflective markers placed on the skin at predefined anatomical positions captured by high 
speed cameras [4, 5, 7, 8, 11-13]. These measurements have a considerable need of resources 
since they require specialized personnel and equipment and are time consuming [14]. Not 
surprisingly, the number of studies reporting on gait analysis in patients with hip OA is in no 
way comparable to the number of studies reporting on other functional outcome measures 
despite of the obvious relevance of ambulatory mechanics in the disease process [15]. 
Moreover, these studies typically report on small cohorts because of the time and cost 
associated with assessments with marker and camera-based systems in gait laboratories. A 
systematic review examining gait analysis as an outcome measure for hip OA concluded that 
one of the main limitations of the existent literature is the insufficient number of patients in 
the studies [3]. 
 
Inertial sensors have risen in popularity as an affordable, time efficient, practical way 
of performing gait analysis [16]. Inertial sensor systems do not require a dedicated laboratory 
and hence are feasible in an outpatient clinic setting and in large cohorts. Several inertial 
sensor systems have been described in the last decade [16]. While most studies on OA using 
inertial sensor systems have focused on knee OA, a few studies performing measurements 
with inertial sensor systems in patients with hip OA have reported spatiotemporal parameters 
[6, 9, 10, 17, 18], but none of these captured joint kinematics. Among inertial sensor systems, 
the RehaGait® system has been shown to provide reliable data that are comparable to an 
instrumented treadmill and camera-based system for measuring spatiotemporal parameters 
and lower limb kinematics in younger and older healthy subjects as well as in patients with 
knee OA and lumbar spinal stenosis [19-23]. 
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The purpose of this study was to investigate the feasibility of using the RehaGait® for 
gait analysis in patients with hip OA. We hypothesized that known spatiotemporal and 
kinematic differences between patients with hip OA and age matched asymptomatic control 
subjects can be measured using the inertial sensor system RehaGait®. 
 
2. Methods 
 
2.1 Participants 
 
Twenty-two patients with severe hip OA were included in this study. Inclusion criteria 
were: age ≥ 30 years; diagnosed unilateral hip OA scheduled for total hip arthroplasty (THA). 
Exclusion criteria were: body mass index (BMI) > 35 kg/m2; use of walking aids; 
neuromuscular disorders affecting gait. Patients were recruited through our outpatient clinic 
as well as through cooperating external orthopaedic clinics. Forty-five control subjects were 
included meeting the inclusion criteria: age ≥ 30 years; and no clinical diagnosis of OA, 
rheumatoid arthritis or history of knee or hip trauma or pain at the time of the measurement. 
Exclusion criteria were: Hip Osteoarthritis Outcome Score (HOOS) < 90 in the pain 
subcategory; BMI > 35 kg/m2; use of walking aids; neuromuscular disorders affecting gait; 
and inability to follow procedures due to psychological disorders or dementia. Control 
subjects were recruited from the local community through advertisements on our internet 
page. All subjects gave written informed consent prior to participation. This study was 
approved by the regional review board and conducted in accordance with the Declaration of 
Helsinki.  
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2.2 Demographic and clinical parameters 
 
Demographic data including age, sex, body mass, height, and BMI were recorded for 
each subject. The HOOS score was used as subjective measure of the patients’ symptoms 
[24]. The HOOS is composed of a total of 40 questions further divided in five subscales 
consisting of 10 questions for pain (HOOS Pain), five for symptoms (HOOS Symptoms), 17 
for activities of daily living (HOOS ADL), four for sport and recreation (HOOS Sport/Rec) 
and four for hip related quality of life (HOOS QOL). A total score is calculated for each 
subcategory with a range from 0-100, higher scores representing better conditions. 
Anteroposterior pelvic x-rays and axial hip x-rays were used to determine the 
Kellgren/Lawrence (K/L) radiographic severity scale of the patients [25]. A K/L grade of 1 on 
the contralateral side was accepted as long as the hip was asymptomatic. The combination of 
a K/L Grade 3 or 4 and symptoms leading to the decision to perform a THA was defined as 
severe hip OA [26]. 
 
2.3 Measurements 
 
The measurements were performed using the RehaGait® (Hasomed, Magdeburg, 
Germany) inertial sensor system. The system consists of seven sensors, each comprising three 
accelerometers, three gyroscopes and a magnetometer. Three sensors were placed at each 
lower extremity (lateral foot, lateral lower leg and lateral thigh) and one on the pelvis 
overlying the 5th lumbar vertebra (Fig. 1). The calibration of the system took place with the 
subject standing for 10 s and then flexing the trunk and each hip alternating. Each subject 
walked for 20 m at a self-selected speed. Spatiotemporal and kinematic parameters for the 
hip, knee and ankle were computed by the manufacturer’s proprietary software (Hasomed, 
Magdeburg, Germany) according to Seel et al. [27]. Spatiotemporal parameters (walking 
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speed, cadence, stride length and duration as well as duration of stance/swing phase and 
single/double support phase as percentage of the gait cycle) as well as time series of hip, knee 
and ankle kinematics were exported. Spatiotemporal and ankle, knee and hip kinematic data 
obtained using this system are comparable to those obtained using a state-of-the-art camera-
based system and is reliable [19, 21, 28]. 
 
2.4 Data processing and statistical analyses 
 
Discrete kinematic parameters including dynamic joint range of motion (ROM), 
minimum and maximum hip, knee and ankle angles during stance and swing were computed 
using a custom algorithm written in Matlab (MathWorks Inc., Natick, MA, USA) from the 
kinematic time series and used for further analyses. Because we were interested in the clinical 
relevance of group and side differences, 95% confidence intervals (CI) were calculated for 
within-subject and between-subject differences in spatiotemporal and kinematic parameters. 
In addition, paired and independent sample t-tests were performed to detect statistically 
significant within-subject and between-subject differences, respectively. The significance 
level was set a priori to 0.05 with a Bonferroni correction to account for multiple comparisons 
resulting in a significance level of 0.025. 
 
The required number of subjects was calculated based on group differences reported in 
the literature [11]. Sample size estimation revealed that 9 participants per group were required 
to detect an expected difference in hip ROM with an effect size of at least 1.33 with 80% power 
at a 5% significance level. We aimed at enrolling 20 participants per group.  
 
3. Results 
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3.1 Clinical evaluation 
 
The demographic parameters of the two groups are presented in Table 1. Each 
subcategory of the HOOS score was significantly lower in the hip OA group, the greatest 
differences were observed in the HOOS QOL (quality of life) subcategory. Nine patients had a 
K/L grade of 3, and 13 patients had a K/L grade of 4.   
 
3.2 Spatiotemporal differences between patients with hip OA and controls 
 
Patients with hip OA had a slower walking speed (-0.18 m/s, P<0.001) and shorter 
stride length than the control subjects (-0.16m, P<0.001; Table 2). While not statistically 
significant, the cadence in patients was lower than in the control group (-4.13 steps/min, 
P=0.116). There was no notable difference in stride duration between groups (+0.05 s, 
P=0.079). Furthermore, the single support phase of the affected leg of the patients, expressed 
as a percentage of the gait cycle, was shorter than that of the healthy group (-2.9%, P<0.001). 
The comparison between legs in patients revealed that the stance phase of the affected side 
was shorter than that of the unaffected side (-2.3%, P=0.019). 
 
3.3 Kinematic differences between the affected leg of the patients and controls 
 
The two legs of the control subjects did not differ in any kinematic parameters 
(P>0.05, Fig.2). Therefore, the left lower extremity parameters were used for further analyses. 
The affected side of the patients had less maximum hip flexion during stance and swing (-
8.0°, P<0.001 and -7.8°, P=0.001, respectively) and less maximum hip extension (-3.5°, 
P<0.001; Table 3). Accordingly, hip ROM in the patients was lower during stance (-11.6°, 
P<0.001) and swing (-11.3°, P<0.001) compared to the control group. The knee of the 
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affected side in patients had a smaller ROM during terminal stance and swing (-9.0° 
and -11.5°, P<0.001, respectively) and a higher minimum flexion angle in the terminal stance 
phase (+7.2°, P<0.001). Lastly, the ankle of the affected side had a higher maximum 
dorsiflexion angle than the control group (+3.5°, P=0.001; Fig.2 and Fig.3).  
 
3.4 Kinematic differences between the affected and the unaffected hip of the patients 
 
The affected side in patients had a smaller hip ROM during stance and swing (-9.3° 
P=0.002 and -9.3°, P=0.004, respectively) and smaller maximum hip flexion during stance and 
swing (-8.1°, P=0.007, and -8.1°, P=0.017, respectively) compared to the unaffected side. 
Furthermore, the affected side had a smaller knee ROM during terminal stance and swing (-7.5° 
and -6.8°, P<0.001, respectively) and a higher minimum knee flexion in the terminal stance 
phase (+4.8°, P<0.001). Lastly, the ankle of the affected side had a higher maximum 
dorsiflexion angle than the contralateral side (+2.5°, P=0.020; Fig.2 and Fig.3).  
 
4. Discussion 
 
We hypothesized that the known spatiotemporal and kinematic differences between 
patients with hip OA and asymptomatic control subjects can be measured using the inertial 
sensor system RehaGait®. The measured differences were in agreement with those reported 
in the literature for marker and camera-based gait analysis systems. To the best of our 
knowledge this is the first study measuring kinematic differences in the hip, knee and ankle 
joints in patients with hip OA with a wearable inertial sensor system. 
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4.1. Spatiotemporal and kinematic differences in patients with hip OA 
 
We measured a slower walking speed and shorter stride length in patients with hip OA 
compared to the asymptomatic individuals. There is strong and consistent evidence in the 
literature, including two systematic reviews [3, 29], that speed and stride length are lower in 
patients with hip OA compared to healthy individuals. Furthermore, we found a shorter single 
support phase in the affected leg of patients with hip OA compared to the control group, 
which is in agreement with all studies reporting on single/double support duration included in 
the systematic review of Constantinou et al [29]. Moreover, the observed shorter stance phase 
in the affected side compared to the unaffected side agrees with earlier studies and indicates 
gait asymmetry [29].  
 
Furthermore, we detected smaller hip ROM during stance and swing in the affected 
hip compared to controls. Although some inconsistency exists regarding the terminology – 
previous studies reported ROMs for the entire gait cycle or in distinct phases of the gait cycle 
– several studies have described similar kinematic changes in patients with hip OA compared 
to controls. For instance, Ornetti et al. [7], Eitzen et al. [11] and Zeni et al. [8] all reported a 
reduction in hip ROM with less maximum flexion and extension of the OA hip. Bejek et al [5] 
confirmed these findings at different walking speeds while Ardestani et al.[4] used statistical 
parametric mapping analysis to explore the kinematic changes over the entire gait cycle and 
reported a reduction in the hip extension angle in early stance and in the hip flexion angle 
between 30 and 70% of the gait cycle. In addition, we observed kinematic changes at the knee 
and ankle of the affected leg. The knee of the affected side in patients had a smaller 
flexion/extension ROM during terminal stance and swing, and the ankle of the affected side 
had a higher peak dorsiflexion angle. While some studies measuring kinematics in patients 
with hip OA did not report data for the knee [8] or ankle [5, 8] and others found the reduction 
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in knee ROM to be not significant [7], several studies already described a reduction in ROM 
of the affected knee in patients with hip OA [4, 5, 11]. In addition, Ornetti et al. [7] reported 
an increased peak ankle dorsiflexion angle in the affected leg. Altogether the kinematic 
differences between patients with OA and control, despite the differences in the terminology, 
analysis and way of presentation, are reported consistently in the literature of camera-based 
systems. This study confirms these findings using a wearable sensor system.  
 
Regarding side to side differences, we found smaller hip ROM and a lower maximum 
hip flexion during stance and swing in the affected compared to the unaffected side. The hip 
extension was less affected, which may be explained by a more symmetrical mechanism of 
compensation with pathologic motion in the pelvis as suggested Bejek et al. [5] although 
pelvic motion was not measured in the present study. Many studies reporting on gait in hip 
OA either did not focus only on unilateral hip OA [11, 12] or did not report direct 
comparisons between the affected and the unaffected side [4, 13]. Therefore, it is not possible 
to draw clear conclusions about the side to side kinematic differences occurring in unilateral 
hip OA. Nonetheless, our results regarding side to side kinematic differences are in agreement 
with the few studies reporting corresponding data. For instance, Zeni et al. [8] reported lower 
maximum hip flexion and extension angles, and Bejek et al. [5] reported lower peaks in hip 
and knee flexion and extension as well as in the ROM. Although side to side differences are 
possibly more difficult to detect because patients with unilateral disease are needed and the 
differences are smaller than those compared to healthy subjects, they are equally interesting 
since they are a clear sign of asymmetry. The similarities in the results of different studies Jo
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investigating unilateral OA – the present study included – shows that these differences 
characterize the gait pattern of unilateral hip OA.  
 
4.2 Wearable inertial sensor applications in patients with hip OA 
 
There is a clear need for an inexpensive, simple and time efficient method of gait 
analysis in patients with hip OA. Marker and camera-based systems have been used in many 
previous studies [4, 5, 7, 8, 11]. Yet, the associated great need for resources has prevented gait 
analysis from being established as standardized quantitative functional assessment to 
supplement clinical and radiological scores in clinical studies. To solve this problem, 
researchers have tried to apply inertial sensor systems in the gait analysis of patients with hip 
OA. Although several similar efforts in patients with knee OA have been successful [14], to 
date in hip OA kinematic measurements of the hip, knee and ankle joints using wearable 
inertial sensor systems have not been reported. Bolink et al.[6] used a single inertial 
measurement unit (MicroStrain® Inertia-Link®) for measuring spatiotemporal parameters 
and pelvic tilt angles. Aminian et al. [9] used a 4-sensor inertial sensor system placed at each 
shank and thigh (Physilog ®) and reported spatiotemporal parameters as well as thigh and 
shank rotations but no sagittal kinematic parameters. Barrois et al. [10] used a system 
comprising four inertial sensors attached to the head, the lower back (L3-L4) and both feet 
(XSens®) measuring acceleration signals and identified parameters discriminating between 
different severity stages of OA. However, they did not report spatiotemporal or joint 
kinematics during gait. Lastly, Rapp et al. [30] measured spatiotemporal parameters in 
patients who received a THA for hip OA.  
 
To date, hip kinematics during gait have not been reported for inertial sensor systems. 
Contrary to knee joint, capturing hip kinematics requires sensors placed at the pelvis and at 
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the legs. Clearly, our results demonstrate that assessing hip kinematics using the sensors of 
the RehaGait® system is feasible. Technical improvements are expected in all inertial sensor 
systems, and hence further studies on hip OA using wearable inertial sensor systems are 
expected to emerge in the following years. The results of our study are promising and may 
serve as comparison for future studies that are needed to confirm these results. Building upon 
our study, data on changes in spatiotemporal parameters and lower extremity kinematics after 
THA can now be generated. Because wearable inertial sensor systems are easy to use and 
time efficient, the use of inertial sensors should increase the number of subjects included in 
studies reporting on hip OA kinematics allowing for using ambulatory mechanics as outcome 
of large clinical trials and facilitate capturing gait data as measures for monitoring quality and 
success of conservative or surgical treatment. Moreover, large data sets on ambulatory 
mechanics in patients with hip and knee OA and other orthopaedic conditions affecting the 
lower extremities will allow to identify specific gait parameters that are characteristic not only 
for the specific condition but also for its severity.  
4.3. Strengths and limitations 
 
The strengths of this study include the homogeneity of the patient group because we 
included only patients with severe unilateral hip OA. Furthermore, participants in the control 
group in our study were matched for age to our patient group. In this first study on the use of 
wearable inertial sensors for measuring spatiotemporal and kinematic difference in gait 
between patients with hip OA and control subjects, we only included a rather small sample 
size. However, in line with our a priori sample size estimation, we found clear and clinically 
relevant spatiotemporal and kinematic differences. The results presented in our study apply 
only to the inertial sensor system RehaGait® and would have to be confirmed for other 
inertial sensor systems. While most inertial sensors comprise similar technology 
(accelerometers, gyroscopes, magnetometers), existing systems differ largely with respect to 
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the underlying computational algorithms and wireless data transfer protocols, and hence the 
comparability among these systems has yet to be shown. 
5. Conclusion 
 
Spatiotemporal and kinematic gait parameters characteristic of patients with hip OA 
can be measured with the RehaGait® inertial sensor system. This system is inexpensive, 
practical, time efficient and requires no specific expertise in the field of biomechanics. 
Therefore, this system is suitable for routine application in clinical practice and for large 
cohort studies. This study clearly showed that the utilization of wearable inertial sensor 
systems for gait analysis in hip OA is feasible.  
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Fig. 1. Views of an individual wearing the RehaGait® inertial sensors. The system consists of 
seven sensors. Three sensors were placed at each lower extremity (lateral foot, lateral lower 
leg and lateral thigh) and one on the pelvis overlying the 5th lumbar vertebra. 
 
Fig. 2. Ankle, knee and hip flexion angles during walking for individual steps for one patient 
with severe hip osteoarthritis (top; red–affected side; blue–unaffected side) and one 
asymptomatic control subject (bottom; grey–left side; black–right side). 
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Fig. 3. Mean ankle (left), knee (middle) and hip (right) kinematics in patients with severe hip 
OA (N=22; affected–red line, unaffected side–blue line) and asymptomatic control subjects 
(N=45; black line). 
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Table 1. Mean (1 standard deviation) characteristics of patients with hip OA scheduled for total hip 
replacement (N=22) and age-matched asymptomatic control subjects (N=45). 
Parameters Patients Asymptomatic 
controls 
P-value 
Sex (male/female) 12/10 16/29 0.139a 
Age (years) 66.3 (10.2) 66.6 (7.4) 0.867b 
Height (m) 1.71 (0.08) 1.69 (0.08) 0.363b 
Body mass (kg) 79.7 (13.2) 71.0 (11.9) 0.008 b 
BMI (kg/m2) 27.3 (3.3) 25.0 (4.1) 0.025 b 
HOOS Pain  98.6 (3.1)  52.3 (15.7) < 0.001 b 
HOOS Symptoms  97.2 (4.7) 48.3 (16.1) < 0.001 b 
HOOS ADL  98.6 (3.6) 53.8 (18.3) < 0.001 b 
HOOS Sport/Rec 98.0 (5.1) 35.1 (23.7) < 0.001 b 
HOOS QOL 97.0 (7.7) 27.2 (15.3) < 0.001 b 
a Chi-square test; b independent sample t test 
BMI – body mass index; HOOS – hip injury and osteoarthritis outcome score; ADL – activities of 
daily living; Rec – recreation; QOL – quality of life. 
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Table 2. Mean (1 standard deviation) spatiotemporal gait parameters in patients with hip OA scheduled for total hip replacement (N=22) and age-matched 
asymptomatic control subjects (N=45). 
Parameter Patients Controls 95% CI patients - controls P value patients - controls 
Stride duration (s)  1.12 (0.13)  1.07 (0.09)  [-0.01; 0.10] 0.079 
Stride length (m)  1.16 (0.17)  1.32 (0.12)  [-0.24; -0.09] <0.001 
Walking speed (m/s)  1.06 (0.22)  1.24 (0.15)  [-0.28; -0.09] <0.001 
Cadence (steps/min)  108.68 (11.83)  112.81 (8.93)  [-9.30; 1.05] 0.116 
Stance phase (%gc)  
(affected side)  63.2 (2.6)  62.4 (2.0)  [-0.4; 2.0] 0.174 
Swing phase (%gc) 
(affected side)  36.8 (2.6)  37.6 (2.0)  [-2.0; 0.4] 0.174 
Single support phase 
(%gc) 
(affected side)  34.7 (4.7)  37.6 (1.7)  [-4.5; -1.3] <0.001 
Double support phase 
(%gc) 
(affected side)  15.0 (4.6)  12.5 (1.6)  [0.9; 4.0] 0.003 
CI—confidence interval, gc – gait cycle 
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Table 3. Mean (1 standard deviation) kinematic gait parameters for the ankle, knee and hip joint in patients with hip OA scheduled for total hip replacement 
(N=22) and age-matched asymptomatic control subjects (N=45). 
 
Parameter Patients Asymptomatic 
controls 
95% CI 
patients -
controls 
95% CI 
affected -
unaffected 
P value 
patients -
controls 
P value 
affected-
unaffected 
Affected Unaffected 
Ankle   
Maximum plantarflexion stance (°) 8.0 (2.9) 8.3 (2.5) 8.7 (1.9) [-1.9; 0.5] [-0.8; 0.6] 0.252 0.810 
Maximum dorsiflexion stance (°) 14.4 (4.6) 11.9 (3.4) 10.9 (3.4) [1.4; 5.4] [0.4; 4.1] 0.001 0.020 
Maximum plantarflexion push of (°) 14.2 (9.1) 15.1 (6.6) 19.3 (5.5) [-8.6; -1.4] [-3.3; 3.2] 0.007 0.966 
Range of motion stance (°) 22.4 (5.8) 20.2 (4.1) 19.6 (4.0) [0.3; 5.2] [0.2; 4.2] 0.027 0.037 
Range of motion push off (°) 28.6 (9.1) 27.0 (6.9) 30.2 (5.9) [-5.3; 2.1] [-1.2; 5.6] 0.391 0.188 
Knee   
Initial contact (°) 4.6 (3.0) 5.9 (2.6) 5.1 (3.9) [-2.5; 1.4] [-2.2; 0.1] 0.602 0.061 
Maximum flexion stance (°) 19.4 (6.8) 22.1 (6.7) 21.2 (5.5) [-5.1; 1.5] [-4.2; 0.5] 0.283 0.111 
Minimum flexion terminal stance (°) 17.0 (7.0) 12.2 (4.6) 9.8 (5.3) [4.0; 10.5] [2.3; 8.1] <0.001 0.001 
Maximum flexion swing (°) 63.7 (11.2) 65.6 (8.6) 67.9 (5.6) [-8.7; 0.2] [-4.5; 1.8] 0.061 0.373 
Range of motion load acceptance (°) 14.9 (4.7) 16.2 (5.6) 16.1 (4.6) [-3.8; 1.3] [-2.9; 1.3] 0.326 0.439 
Range of motion terminal stance (°) 2.4 (3.8) 9.9 (5.6) 11.4 (5.3) [-11.7; -6.4] [-9.1; -5.0] <0.001 <0.001 
Range of motion swing (°) 46.6 (8.0) 53.4 (5.5) 58.1 (5.3) [-15.0; -8.0] [-9.6; -3.5] <0.001 <0.001 
Hip   
Maximum flexion stance (°) 22.8 (6.7) 30.9 (8.5) 30.8 (7.0) [-11.7; -4.4] [-12.9; -2.3] <0.001 0.007 
Maximum extension stance (°) 4.8 (2.8) 6.0 (3.1) 8.3 (3.2) [-5.2; -1.9] [-2.9; 0.7] <0.001 0.221 
Maximum flexion swing (°) 25.0 (6.3) 33.1 (10.5) 32.8 (8.7) [-12.0; -3.5] [-13.8; -1.5] 0.001 0.017 
Range of motion stance (°) 27.6 (7.6) 36.9 (9.6) 39.2 (8.4) [-15.9; -7.2] [-13.9; -3.5] <0.001 0.002 
Range of motion swing (°) 29.8 (6.7) 39.1 (10.9) 41.1 (10.3) [-16.2; -6.3] [-14.3; -3.2] <0.001 0.004 
CI—confidence interval 
 
 Jo
urn
al 
Pre
-pr
oo
f
